{"id": "1355280226536853504", "creation": 1611958960.0, "user_id": "915371022039310336", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 1, "reply_count": 0, "like_count": 2, "quote_count": 0}}, "text": "Johnson &amp; Johnson says there's more to its #coronavirus #vaccine's headline 66% efficacy in Phase 3 than meets the eye as it draws negative comparisons to mRNA vaccines &amp; stock closes down 3.5%. My piece today in @PharmaScrip. #COVID19 #CovidVaccine $JNJ\n\nhttps://t.co/jud3pdPzU0", "first_save": 1634559108.199414, "hashtags": ["#CORONAVIRUS", "#VACCINE", "#COVID19", "#COVIDVACCINE"]}